Evidence & citations 3 cited values
Every value below carries the sentence it was read from.
2 sources stand behind the page.
| Field | Value | Cited text |
|---|
| Known as |
LY-CovMab |
ClinicalTrials.gov intervention name — accepted as the source's own label NCT04973735 ↗
|
| Modality |
Monoclonal antibody |
“The pharmacokinetic (PK) profiles of LY-CovMab in healthy adults showed typical monoclonal antibody distribution and elimination characteristics.” PMID 34878625 ↗ Dec 2021
|
| Route |
Intravenous |
“single IV infusion” NCT04973735 ↗
|